Provided By GlobeNewswire
Last update: May 1, 2025
JUPITER, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well as non-pharmaceutical applications including food, non-food and industrial applications, today announced that it will report its financial results for the first quarter 2025 and host a corporate update conference call on Wednesday, May 14, 2025.
Read more at globenewswire.comNASDAQ:DYAI (11/7/2025, 3:01:31 PM)
0.94
-0.04 (-4.08%)
Find more stocks in the Stock Screener


